Bergin Michael Joseph Gerard, Hirata Rogerio, Mista Christian, Christensen Steffan Wittrup, Tucker Kylie, Vicenzino Bill, Hodges Paul, Graven-Nielsen Thomas
School of Health and Rehabilitation Sciences, NHMRC Centre of Clinical Research Excellence in Spinal Pain, Injury and Health, Brisbane, Queensland, Australia.
Center for Neuroplasticity and Pain (CNAP), SMI, Department of Health Science and Technology, Faculty of Medicine, Aalborg University, Aalborg, Denmark.
Pain Med. 2015 Nov;16(11):2180-91. doi: 10.1111/pme.12824. Epub 2015 Jul 14.
Lateral epicondylalgia presents as lateral elbow pain provoked by upper limb tasks. An experimental model of elbow pain provoked by movement/muscle contraction and maintained over several days is required to better understand the mechanisms underlying sustained elbow pain. This study investigated the time course and pain location induced by nerve growth factor (NGF) injection into a wrist extensor muscle, and whether movement and muscle contraction/stretch provoked pain.
On Day 0 twenty-six painfree volunteers were injected with NGF (N = 13) or isotonic saline (randomized) into the extensor carpi radialis brevis (ECRB) muscle of the dominant arm. On Day 2 pain was induced in all participants by hypertonic saline injection into ECRB. A Likert scale and patient-rated tennis elbow evaluation (PRTEE) was used to assess pain and functional limitation (Days 0-10). Pain intensity during contraction/stretch of ECRB, and pressure pain thresholds (PPTs) were recorded before and after injections on Days 0 and 2, and Days 4 and 10.
Compared with isotonic saline, NGF evoked: i) greater Likert pain ratings from 12 hours post-injection until Day 6, ii) greater PRTEE scores on Days 2 and 4, iii) greater pain during ECRB contraction/stretch on Day 2, and iv) lower PPTs on Day 4.
This article presents a novel experimental human pain model suitable to study the sustained effects of lateral elbow pain on sensorimotor function and to probe the mechanisms underlying persistent musculoskeletal pain.
外侧上髁炎表现为上肢活动诱发的肘部外侧疼痛。需要一个由运动/肌肉收缩诱发并持续数天的肘部疼痛实验模型,以更好地理解持续性肘部疼痛的潜在机制。本研究调查了向腕伸肌注射神经生长因子(NGF)诱发的疼痛时间进程和疼痛部位,以及运动和肌肉收缩/拉伸是否会诱发疼痛。
在第0天,26名无疼痛的志愿者被随机注射NGF(N = 13)或等渗盐水到优势手臂的桡侧腕短伸肌(ECRB)中。在第2天,所有参与者通过向ECRB注射高渗盐水诱发疼痛。使用李克特量表和患者自评网球肘评估(PRTEE)来评估疼痛和功能受限情况(第0 - 10天)。在第0天、第2天、第4天和第10天注射前后记录ECRB收缩/拉伸时的疼痛强度以及压痛阈值(PPTs)。
与等渗盐水相比,NGF诱发:i)注射后12小时至第6天李克特疼痛评分更高;ii)第2天和第4天PRTEE评分更高;iii)第2天ECRB收缩/拉伸时疼痛更剧烈;iv)第4天PPTs更低。
本文提出了一种新型的人体疼痛实验模型,适用于研究外侧肘部疼痛对感觉运动功能的持续影响,并探究持续性肌肉骨骼疼痛的潜在机制。